Recombinant Human Major facilitator superfamily domain-containing protein 8 (MFSD8),partial CSB-EP844087HU1
Specifications
| 20ug / 100ug / 1mg price = 100ug |
Alternative Name(s):
Ceroid-lipofuscinosis neuronal protein 7
Species: (Organism)
Homo sapiens (Human)
Gene Names:
MFSD8
Tag info:
N-terminal 6xHis-GST-tagged
Target Protein AA Sequence:
MAGLRNESEQEPLLGDTPGSREWDILETEEHYKSRWRSIR
Expression Region:
1-40aa
Subcellular Location:
Lysosome membrane, Multi-pass membrane protein
Tissue Specificity:
Expressed at very low levels in all tissues tested.
Protein Length:
Partial
Pathway:
Mol. Weight:
34.8 kDa
Purity:
Greater than 90% as determined by SDS-PAGE.
Form:
Liquid or Lyophilized powder
Buffer:
If the delivery form is liquid, the default storage buffer is Tris/PBS-based buffer, 5%-50% glycerol. If the delivery form is lyophilized powder, the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, pH 8.0.
Research Areas:
Others
Function:
May be a carrier that transport small solutes by using chemiosmotic ion gradients.
Involvement in disease:
Ceroid lipofuscinosis, neuronal, 7 (CLN7); Macular dystrophy with central cone involvement (CCMD)
Relevance:
May be a carrier that transport small solutes by using chemiosmotic ion gradients
Reconstitution:
We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20℃/-80℃. Our default final concentration of glycerol is 50%. Customers could use it as reference.
Protein Families:
Major facilitator superfamily
Reference:
"Generation and annotation of the DNA sequences of human chromosomes 2 and 4."Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L., Du H. Wilson R.K.Nature 434:724-731(2005)
